Literature DB >> 12601549

Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas.

Hisaki Nagai1, Tetsuji Naka, Yoshie Terada, Toshiaki Komazaki, Aya Yabe, Enjing Jin, Oichi Kawanami, Tadamitsu Kishimoto, Noboru Konishi, Mitsutoshi Nakamura, Yasuhito Kobayashi, Mitsuru Emi.   

Abstract

We recently demonstrated inactivation in hepatocellular carcinomas (HCCs) of the gene encoding SOCS1/JAB1/SSI-1, a JAK-binding protein that regulates the JAK/STAT signal-transduction pathway. In a follow-up immunochemical investigation of expression of SOCS-1 in hepatoblastomas (HBLs), the protein was markedly reduced in half of the HBL tumors we examined. CpG-rich regions upstream of the SOCS-1 gene were hypermehylated in 7 of the 15 HBL cases. The results suggest that hypermethylation may play an important role in silencing the SOCS-1 gene, not only in adult HCCs, but also in liver tumors arising in childhood.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601549     DOI: 10.1007/s100380300008

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  19 in total

1.  Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.

Authors:  R C Sobti; Neha Singh; Showket Hussain; Vanita Suri; Raje Nijhawan; A C Bharti; Mausumi Bharadwaj; B C Das
Journal:  Cell Oncol (Dordr)       Date:  2011-09-21       Impact factor: 6.730

2.  Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.

Authors:  John C Cooper; Mingjian Shi; Fu-Yu Chueh; Srividya Venkitachalam; Chao-Lan Yu
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

Review 3.  The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition.

Authors:  Sylvane Desrivières; Christian Kunz; Itamar Barash; Vida Vafaizadeh; Corina Borghouts; Bernd Groner
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

4.  Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma.

Authors:  I Tischoff; U R Hengge; M Vieth; C Ell; M Stolte; A Weber; W E Schmidt; A Tannapfel
Journal:  Gut       Date:  2007-03-21       Impact factor: 23.059

Review 5.  Suppression of cytokine signaling: the SOCS perspective.

Authors:  Edmond M Linossi; Jeffrey J Babon; Douglas J Hilton; Sandra E Nicholson
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

Review 6.  Targeting JAK kinase in solid tumors: emerging opportunities and challenges.

Authors:  M Buchert; C J Burns; M Ernst
Journal:  Oncogene       Date:  2015-05-18       Impact factor: 9.867

7.  Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.

Authors:  Feng-Ju Huang; Patricia S Steeg; Janet E Price; Wen-Tai Chiu; Ping-Chieh Chou; Keping Xie; Raymond Sawaya; Suyun Huang
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 8.  Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia.

Authors:  Sampa Ghoshal Gupta; Heinz Baumann; Meir Wetzler
Journal:  Leuk Res       Date:  2008-01-14       Impact factor: 3.156

9.  SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.

Authors:  Biao He; Liang You; Kazutsugu Uematsu; Keling Zang; Zhidong Xu; Amie Y Lee; Joseph F Costello; Frank McCormick; David M Jablons
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

10.  DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells.

Authors:  Shuang Bing Xu; Xiao Hong Liu; Ben Hui Li; Yan Zhang; Jia Yuan; Qin Yuan; Pin Dong Li; Xian Zi Yang; Feng Li; Wen Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-24       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.